Carl Zeiss Meditec AG (CZMWY)
34.16
-0.98
(-2.79%)
USD |
OTCM |
Oct 05, 16:00
Carl Zeiss Meditec Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2016 | 28.29M |
| June 30, 2016 | 48.55M |
| March 31, 2016 | 38.96M |
| December 31, 2015 | 8.040M |
| September 30, 2015 | 52.83M |
| June 30, 2015 | 7.808M |
| March 31, 2015 | 15.42M |
| December 31, 2014 | -11.21M |
| September 30, 2014 | 32.79M |
| June 30, 2014 | 23.54M |
| March 31, 2014 | 38.66M |
| December 31, 2013 | -8.178M |
| September 30, 2013 | 44.25M |
| June 30, 2013 | 16.22M |
| March 31, 2013 | 14.82M |
| December 31, 2012 | 9.095M |
| September 30, 2012 | 38.45M |
| June 30, 2012 | 28.84M |
| March 31, 2012 | 38.35M |
| December 31, 2011 | 12.86M |
| September 30, 2011 | 38.34M |
| June 30, 2011 | 5.242M |
| March 31, 2011 | 11.96M |
| December 31, 2010 | -3.043M |
| September 30, 2010 | 24.27M |
| Date | Value |
|---|---|
| June 30, 2010 | 23.45M |
| March 31, 2010 | 27.52M |
| December 31, 2009 | 11.42M |
| September 30, 2009 | 38.98M |
| June 30, 2009 | 42.07M |
| March 31, 2009 | 31.07M |
| December 31, 2008 | 5.248M |
| September 30, 2008 | 39.77M |
| June 30, 2008 | 19.27M |
| March 31, 2008 | 16.99M |
| December 31, 2007 | 7.569M |
| September 30, 2007 | 40.36M |
| June 30, 2007 | 0.5063M |
| March 31, 2007 | 10.11M |
| December 31, 2006 | 23.03M |
| September 30, 2006 | 26.93M |
| June 30, 2006 | 2.899M |
| March 31, 2006 | 15.74M |
| December 31, 2005 | 7.151M |
| September 30, 2005 | 32.25M |
| June 30, 2005 | 6.429M |
| March 31, 2005 | 2.894M |
| December 31, 2004 | 8.496M |
| September 30, 2004 | 17.77M |
| June 30, 2004 | 10.91M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
| QuidelOrtho Corp. | -110.60M |
| Smith & Nephew plc | -- |
| Trinity Biotech Plc | -- |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | 271.05M |
| Free Cash Flow Yield | 9.06% |